Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Agios Pharmaceuticals, Inc. | StockGist | StockGist

Companies
AGIO
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings AGIOSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Agios Pharmaceuticals, Inc.

Filed Feb 9, 2026

Accepted Feb 9, 2026, 12:00 AM ET

CIK 0001439222

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

AGIOS PHARMACEUTICALS, INC.

Person Type

HC

CUSIP: 00847X104

Amendment History

8 filings

SCHEDULE 13G
Original
Viewing
Feb 9, 20260000093751-26-000018
SCHEDULE 13G/A
Amendment 1
Feb 4, 20250000908834-25-000038
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250001104659-25-013933
SCHEDULE 13G/A
Amendment 3
Jun 13, 20250001104659-25-059295
SCHEDULE 13G/A
Amendment 4
Jul 17, 20250002052113-25-002989
SCHEDULE 13G/A
Amendment 5
Nov 14, 20250001104659-25-112633
SCHEDULE 13G/A
Amendment 6
Dec 5, 20250001104659-25-118951
SCHEDULE 13G/A
Amendment 7
Latest
Feb 9, 20260000908834-26-000066

Recent Filings

Agios Pharmaceuticals, Inc.1 weeks ago

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Agios Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice